Publication | Open Access

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Opioid EpidemicComparative EffectivenessSubstance AbuseOpioid Relapse PreventionAddiction TreatmentAddictionPharmacologyAddiction MedicinePharmacotherapyMedicineHarm ReductionOpioid Use DisorderHealth Sciences